RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceutical Co Stock

Lotus Pharmaceutical Co ROCE 2024

Lotus Pharmaceutical Co ROCE

0.28

Ticker

1795.TW

ISIN

TW0001795003

In 2024, Lotus Pharmaceutical Co's return on capital employed (ROCE) was 0.28, a -4.58% increase from the 0.3 ROCE in the previous year.

Lotus Pharmaceutical Co Aktienanalyse

What does Lotus Pharmaceutical Co do?

The Lotus Pharmaceutical Co. Ltd is a leading pharmaceutical conglomerate based in Taiwan. The company was founded in 1964 and has since become one of the most significant manufacturers of pharmaceutical products in Asia. In recent years, Lotus Pharm has undergone a strategic expansion into international markets and is now present in other countries such as Europe and the USA with its innovative products. The company's business model includes the manufacturing and distribution of pharmaceuticals, medical devices, and dietary supplements. The company relies on close collaboration with partners from the science and research sectors to constantly develop innovative products. The core divisions include Cardiovascular, Endocrinology, Gastroenterology, Immunology, Infectious Diseases, Neurology, Oncology, and Respiratory. In the Cardiovascular division, Lotus Pharm offers a range of products for the treatment of cardiovascular diseases. These include medications for lowering blood pressure, lowering cholesterol levels, and preventing blood clots. The Endocrinology division, on the other hand, provides medications for treating hormonal disorders and metabolic diseases. Examples of these are medications for treating diabetes or thyroid diseases. The Gastroenterology division includes products for the treatment of stomach and intestinal diseases, including medications for reflux, stomach problems, or digestive disorders. Immunology deals with medications for treating autoimmune diseases and allergic conditions, while Infectious Diseases offers medications for infectious diseases. Neurology, on the other hand, includes medications for the treatment of neurological diseases such as pain, migraines, epilepsy, or Alzheimer's. Another important area is Oncology, in which Lotus Pharm offers products for the treatment of cancer. In recent years, the company has introduced numerous innovative medications to the market, which can improve survival rates and enhance the quality of life for cancer patients. Lotus Pharm's product range also includes a range of dietary supplements that are intended to provide the body with essential nutrients and contribute to maintaining health and well-being. Lotus Pharm's products are manufactured in modern production facilities that adhere to the highest quality standards. To meet these high standards, the company relies on continuous monitoring of the manufacturing processes and strict quality assurance. Another crucial factor for the success of Lotus Pharm is its close collaboration with partners from the science and research sectors. The company works closely with leading scientists and researchers to continually gain new insights and promote innovation. In recent years, the company has also expanded into the international market and is now represented in Europe and the USA with its products. This demonstrates that Lotus Pharm's products are in high demand outside of Asia and enjoy international recognition. Overall, it can be said that Lotus Pharmaceutical Co. Ltd is a leading company in the pharmaceutical industry. The close collaboration with researchers and partners, the high quality of the products, and the constant innovation make the company a significant player in the industry. Lotus Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Lotus Pharmaceutical Co's Return on Capital Employed (ROCE)

Lotus Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Lotus Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Lotus Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Lotus Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Lotus Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Lotus Pharmaceutical Co this year?

The ROCE of Lotus Pharmaceutical Co is 0.28 undefined this year.

How has the ROCE (Return on Capital Employed) of Lotus Pharmaceutical Co developed compared to the previous year?

The ROCE of Lotus Pharmaceutical Co has increased by -4.58% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Lotus Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Lotus Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Lotus Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Lotus Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Lotus Pharmaceutical Co impact the company?

An increase in the ROCE of Lotus Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Lotus Pharmaceutical Co affect the company?

A decrease in ROCE of Lotus Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Lotus Pharmaceutical Co?

Some factors that can affect Lotus Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Lotus Pharmaceutical Co so important for investors?

The ROCE of Lotus Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Lotus Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Lotus Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Lotus Pharmaceutical Co pay?

Over the past 12 months, Lotus Pharmaceutical Co paid a dividend of 3.46 TWD . This corresponds to a dividend yield of about 1.33 %. For the coming 12 months, Lotus Pharmaceutical Co is expected to pay a dividend of 4.11 TWD.

What is the dividend yield of Lotus Pharmaceutical Co?

The current dividend yield of Lotus Pharmaceutical Co is 1.33 %.

When does Lotus Pharmaceutical Co pay dividends?

Lotus Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, August, September.

How secure is the dividend of Lotus Pharmaceutical Co?

Lotus Pharmaceutical Co paid dividends every year for the past 6 years.

What is the dividend of Lotus Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 4.11 TWD are expected. This corresponds to a dividend yield of 1.58 %.

In which sector is Lotus Pharmaceutical Co located?

Lotus Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceutical Co from 8/30/2024 amounting to 4.647 TWD, you needed to have the stock in your portfolio before the ex-date on 8/5/2024.

When did Lotus Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/30/2024.

What was the dividend of Lotus Pharmaceutical Co in the year 2023?

In the year 2023, Lotus Pharmaceutical Co distributed 1.931 TWD as dividends.

In which currency does Lotus Pharmaceutical Co pay out the dividend?

The dividends of Lotus Pharmaceutical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceutical Co

Our stock analysis for Lotus Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.